**The Middle East Association Of Pharmaceutical Medicine P1207510 Receipts and payments accounts For the period** 19/03/2024 06/06/2025 **To from** ## **CC16a** ## **Section A Receipts and payments** |**A1 Receipts**|**Unrestricted**
**funds**
**to the nearest**
**£**
**24,000**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**24,000**
**-**
**-**
**-**
**24,000**
**10,028**
**7,313**
**12,309**
**2,161**
**100**
**73,820**
**-**
**-**
**105,731**
**322**
**-**
**322**
**106,053**
**- 82,053**
**-**
**-**
**- 82,053**|**Restricted**
**funds**
**to the nearest £**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**|**Endowment**
**funds**
**to the nearest £**|**Total funds**
**to the nearest £**
**24,000**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**24,000**
**-**
**-**
**-**
**24,000**
**10,028**
**7,313**
**12,309**
**2,161**
**100**
**-**
**73,820**
**-**
**-**
**105,731**
**322**
**-**
**322**
**106,053**
**- 82,053**|**Total funds**
**to the nearest £**
**24,000**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**24,000**
**-**
**-**
**-**
**24,000**
**10,028**
**7,313**
**12,309**
**2,161**
**100**
**-**
**73,820**
**-**
**-**
**105,731**
**322**
**-**
**322**
**106,053**
**- 82,053**|**Last year**
**to the nearest £**| |---|---|---|---|---|---|---| |British Council Grant|**24,000**||**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**|**24,000**||**-**| ||**-**|||**-**||**-**| ||**-**|||**-**||**-**| ||**-**|||**-**||**-**| ||**-**|||**-**||**-**| ||**-**|||**-**||**-**| ||**-**|||**-**||**-**| ||**-**|||**-**||**-**| |**_Sub total_**_(Gross income for_
_AR)_|**24,000**|||**24,000**||**-**| |||||||| |**A2 Asset and investment sales,**
**(see table).**||||||| ||**-**||**-**
**-**
**-**|**-**||| ||**-**|||**-**||**-**| |**_Sub total_**|**-**|||**-**||**-**| |**_Total receipts_**
**A3 Payments**||||||| ||||**-**|**24,000**||**-**| |||||||| |Rent and office|**10,028**||**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**|**10,028**||| |Motor and travel|**7,313**|||**7,313**||**-**| |Payroll|**12,309**|||**12,309**||**-**| |Professional|**2,161**|||**2,161**||**-**| |Other|**100**|||**100**||**-**| |||||**-**||**-**| |Pre set upexpenditure|**73,820**|||**73,820**||**-**| ||**-**|||**-**||**-**| ||**-**|||**-**||**-**| |**_Sub total_ **|**105,731**|||**105,731**||**-**| |||||||| |**A4 Asset and investment**
**purchases, (see table)**||||||| |**Office equipment**|**322**||**-**
**-**
**-**|**322**||| ||**-**|||**-**||| |**_Sub total_ **|**322**|||**322**||**-**| |**_Total payments_**
**_Net of receipts/(payments)_**
**A5 Transfers between funds**
**A6 Cash funds last year end**
**_Cash funds this year end_**||||||| ||||**-**|**106,053**||**-**| |||||||| ||**- 82,053**|**-**|**-**|**- 82,053**||**-**| ||**-**|**-**|**-**
**-**|**-**||**-**| ||**-**|**-**||**-**||**-**| ||**- 82,053**|**-**|**-**|**- 82,053**||**-**| CCXX R1 accounts (SS) 05/05/2026 1 ## **Section B Statement of assets and liabilities at the end of the period** |**Categories**
Signed by one or two trustees on
behalf of all the trustees
**B1 Cash funds**
**B2 Other monetary assets**
**B4 Assets retained for the**
**charity’s own use**
**B5 Liabilities**
**B3 Investment assets**|Signature
**Details**
**Details**
Office equipment
Held at Kings College
Cash book
**Details**
**Details**
**_Total cash funds_**
(agree balances with receipts and payments
account(s))
**Details**|**Unrestricted**
**funds**
**Restricted**
**funds**
**to nearest £**
**to nearest £**
**24,000**
**-**
**- 106,053**
**-**
**-**
**-**
**- 82,053**
**-**
OK
OK
**Unrestricted**
**funds**
**Restricted**
**funds**
**to nearest £**
**to nearest £**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**Fund to which asset**
**belongs**
**Cost (optional)**
**-**
**-**
**-**
**-**
**-**
**Fund to which asset**
**belongs**
**Cost (optional)**
Unrestricted
**322**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**Fund to which**
**liability relates**
**Amount due**
**(optional)**
**-**
**-**
**-**
**-**
**-**
Print Name
Dr Assem el Baghdady|**Endowment**
**funds**
**to nearest £**| |---|---|---|---| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||OK| ||||**Endowment**
**funds**
**to nearest £**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**Current value**
**(optional)**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**Current value**
**(optional)**| ||||**241**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**When due**
**(optional)**| ||||| ||||| ||||| ||||| ||||| ||||| ||||Date of
approval| |||Dr Assem el Baghdady|| ||||| CCXX R2 accounts (SS) 05/05/2026 2